All News

The first outline of how the proposed European Research Council will try to stem the brain drain of Europe’s best young researchers has been sketched in by its governing body.

What's hot for for 2006? Spin-outs and carve-outs, says senior Atlas Venture partner Christopher Spray in an interview for Science|Business

The European Research Council, the EU's new plaything, is looking for a Secretary General.

Bath University is looking for partners or investors to take forwards a protoype fuel-efficient runaround vehicle – part micro-car, part motorcycle.

A new high-accuracy low-cost infusion pump has attracted £250,000 funding from The Capital Fund, a £50 million venture capital fund that invests in fast-growth companies in Greater London.

Some large wave and tidal projects are now coming to fruition, but they will need to secure a premium price for the electricity they generate.

The UK government has moved to promote the wider adoption of non-fossil fuels with a new action plan to unlock the potential for renewable energy in biomass.

Spend more on basic research - that's one of the prescriptions for Europe offered by Jim Goodnight, founder and CEO of SAS, one of the world's largest privately held software companies.

Searching for the best tax incentives in European R&D? Then look no further than the Science|Business guide to this popular - though by no means universal - stimulant.

The review of intellectual property rights in the UK have created some strange allies.

Inexpensive, fun applications can make a big splash in the consumer robotics market, but investors are waiting for a new 'killer app' before putting their money on the table.

Hailed as one of the most important recent discoveries in biology, RNA interference has seen patent applications rise 3,000 per cent between 2000 and 2003.

Philips has announced the first fruit of its deal with the venture capital firm New Venture Partners to spin out companies based on research carried out in Philips’ corporate research laboratories.

While US companies have halted research into plant-made pharmaceuticals - or even gone bust - European companies are pressing ahead

The Finnish developers of a virtual guitar are looking for investment to develop the technology and to bring it to public venues.